Factors Associated With Pregnancy Loss in IVF Women
Factors Associated With Second-Trimester Pregnancy Loss in Women With Normal Uterine Anatomy Undergoing In Vitro Fertilization
1 other identifier
observational
500
1 country
1
Brief Summary
Maternal and clinical characteristics associated with spontaneous second-trimester pregnancy loss (between 12 1/7 and 23 6/7 weeks of gestation) will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2015
CompletedFirst Posted
Study publicly available on registry
March 9, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedApril 5, 2017
April 1, 2017
2.1 years
March 4, 2015
April 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
second trimester abortion
between 12 1/7 and 23 6/7 weeks of gestation)
Study Arms (2)
aborted women
women who got pregnant and have 2nd trimesteric abortion, follow up antenatal care by ultrasound and clinical monitoring
continued women
women who got pregnant and completed her pregnancy follow up antenatal care by ultrasound and clinical monitoring
Interventions
Eligibility Criteria
Women aged 21-44 years with ongoing in vitro fertilization pregnancy (at least one fetus with fetal heart tones at 12 weeks of gestation)
You may qualify if:
- Women aged 21-44 years with ongoing in vitro fertilization pregnancy (at least one fetus with fetal heart tones at 12 weeks of gestation)
You may not qualify if:
- abnormal uterine cavity induced abortion for medical problem
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Ahmed Maged
Cairo, 12151, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Maged, MD
Kasr Alainy medical school
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
March 4, 2015
First Posted
March 9, 2015
Study Start
April 1, 2015
Primary Completion
May 1, 2017
Study Completion
August 1, 2017
Last Updated
April 5, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will share